Clinical Trials

130 enrolled

Locally Advanced Rectal Cancer

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

258 enrolled

Breast Neoplasms

NCT06787183 2026-03-03

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

42 enrolled

Locally Advanced Rectal Cancer With Liver Metastases

NCT07331428 2026-01-09

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

25 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT07185672 2025-09-22

PReCedeNT

Phase 3 Recruiting

162 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06333769 2025-08-15

Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer

Phase 2 Completed

38 enrolled

Phase 2 Active not recruiting

Mid-low Rectal Cancer

NCT04864067 2025-07-01

NOAHS-ARC

73 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT06888843 2025-03-27

AHTCRR-1

160 enrolled

Colorectal Neoplasms

NCT06598046 2024-09-19

A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

48 enrolled

Breast Neoplasms

NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

240 enrolled

Advanced Breast Cancer

NCT06490913 2024-07-08

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

33 enrolled

Liver Metastases of Colorectal Cancer

NCT06475443 2024-06-26

Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs

32 enrolled

Phase 2 Active not recruiting

Metastatic Breast Cancer in the Brain

NCT03756298 2023-11-09

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

284 enrolled

Triple Negative Breast Neoplasms

NCT03691051 2023-09-25

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

78 enrolled

HER2 Positive Metastatic Breast Cancer

NCT05479240 2023-06-18

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

94 enrolled

Immunotherapy

NCT05608785 2022-11-08

Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes

Phase 1/2 Unknown

45 enrolled

Stomach Neoplasms

NCT05207735 2022-01-26

SCRCA

73 enrolled

Cholangiocarcinoma

NCT00070213 2021-09-27

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Completed

460 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00640081 2021-09-22

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

Phase 2 Completed

169 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04351867 2020-07-16

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

Phase 3 Unknown

196 enrolled

Stomach Neoplasms

NCT04220528 2020-01-07

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

129 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02741856 2018-10-25

SCOPE2

Phase 2/3 Unknown

584 enrolled

Esophageal Neoplasms

NCT01952951 2017-09-13

PREPARE

110 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT00450203 2016-12-01

ST03

Phase 2/3 Unknown

1,103 enrolled

Oesophagogastric Cancer

NCT02137356 2015-09-03

Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Phase 1 Unknown

28 enrolled

Rectal Neoplasms

NCT01843829 2014-03-24

NeoSCOPE

85 enrolled

Esophageal Neoplasms

NCT01501669 2012-07-18

PROCEED

Phase 3 Unknown

222 enrolled

Breast Neoplasms

NCT00658840 2012-04-03

Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma

55 enrolled

Pancreatic Neoplasms

NCT00352378 2011-06-27

Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer

Phase 3 Completed

209 enrolled

Breast Neoplasms

NCT01331928 2011-04-08

Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer

51 enrolled

Stomach Neoplasms

NCT00453323 2010-07-12

Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

33 enrolled

Esophageal Neoplasms

NCT00580359 2008-01-08

S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

96 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT00506168 2007-07-25

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Phase 2 Terminated

37 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00506844 2007-07-25

ERBIRIX

40 enrolled